NCT04956367

Efficacy of Fractional Carbon Dioxide Laser Combined With Platelet-rich Plasma

Efficacy of Ablative Fractional Carbon Dioxide Laser Combined With Autologous Platelet-rich Plasma Versus Ablative Fractional Carbon Dioxide Laser and Placebo in the Treatment of Striae Gravidarum: a Randomized Clinical Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Jose R. Reyes Memorial Medical Center · Other Government
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study determined the efficacy of ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma versus ablative fractional carbon dioxide laser with placebo in the treatment of striae gravidarum of postpartum Filipino women.

Conditions

• Striae Gravidarum

Interventions

Type	Name	Description
PROCEDURE	Ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma	Carbon dioxide laser (Smaxel.878.4810) was FDA-approved device used in dermatology practice. PRP was described as having growth factors to be used to promote healing.
DEVICE	CO2 laser with PRP	CO2 laser with PRP
DEVICE	CO2 laser with placebo	CO2 laser with placebo

Timeline

• Start date: 2019-07-01
• Primary completion: 2019-10-31
• Completion: 2019-11-30
• First posted: 2021-07-09
• Last updated: 2021-07-09

Locations

1 site across 1 country: Philippines

Regulatory

• FDA-regulated device study